Debra Sherman – Page 2

Doctor urges limited use of Boston Scientific’s new device

August 23, 2021 at 8:32 p.m.

CHICAGO (Reuters) - Boston Scientific Corp's new leadless implantable heart defibrillator, hailed by some as a breakthrough, should be used on a limited basis until more data are collected, a...

Doctor urges limited use of Boston Scientific’s new device

May 13, 2019 at 10:29 p.m.

CHICAGO (Reuters) - Boston Scientific Corp's new leadless implantable heart defibrillator, hailed by some as a breakthrough, should be used on a limited basis until more data are collected, a...

Baxter to buy Sweden’s Gambro for $4 billion

August 23, 2021 at 6:49 p.m.

(Reuters) - Baxter International Inc said on Tuesday it would buy privately held Swedish kidney dialysis product company Gambro AB for about $4 billion, a tie-up that would make it...

Baxter to buy Sweden’s Gambro for $4 billion

December 25, 2018 at 7:41 a.m.

(Reuters) - Baxter International Inc said on Tuesday it would buy privately held Swedish kidney dialysis product company Gambro AB for about $4 billion, a tie-up that would make it...

Top medical innovations address headache, diabetes, cancer

December 24, 2018 at 11:55 p.m.

(Reuters) - The best medical innovations for next year include an almond-size device that's implanted in the mouth to relieve severe headaches and a hand-held scanner resembling a blow dryer...

Aetna to buy Coventry in Medicare, Medicaid expansion

August 23, 2021 at 12:37 p.m.

CHICAGO (Reuters) - Health insurer Aetna Inc said on Monday that it would buy rival Coventry Health Care Inc for $5.6 billion to increase its share of the fast-growing, U.S....

Aetna to buy Coventry in Medicare, Medicaid expansion

December 24, 2018 at 1:01 p.m.

CHICAGO (Reuters) - Health insurer Aetna Inc said on Monday that it would buy rival Coventry Health Care Inc for $5.6 billion to increase its share of the fast-growing, U.S....

Insight: As lawsuits climb, J&J may have new hip trauma

August 23, 2021 at 10:30 a.m.

CHICAGO (Reuters) - Johnson & Johnson faces a potentially more damaging and costly sequel to the $3 billion recall of its ASR all-metal artificial hips two years ago, one of...

Insight: As lawsuits climb, J&J may have new hip trauma

December 24, 2018 at 9:11 a.m.

CHICAGO (Reuters) - Johnson & Johnson faces a potentially more damaging and costly sequel to the $3 billion recall of its ASR all-metal artificial hips two years ago, one of...

U.S. cancer survivors face new test in long-term care

August 23, 2021 at 8:46 a.m.

CHICAGO (Reuters) - Mario Alberico got his education in oncology the hard way. He has lived with cancer and the long-term effects of his treatment for most of his life....

All Stories